Join Toby Batten, Statistics Manager at Veramed and our special guest co-host, Carlo Lanza, as they discuss the evolution, challenges and road ahead of Clinical Oncology - focusing on Phase I, II and III specifically. Carlo and Toby will share how to think outside the box from a clinical and statistical point of view, address common pitfalls, improve study design, and more.
Carlo brings over 20 years of clinical experience having worked for companies such as Pfizer, Novartis and Astrazeneca, while Toby brings over 10 years of statistical experience and is an Oncology specialist at Veramed.
Register to improve your analysis, efficiency and discover a new way of thinking in a fast changing world of clinical Oncology.